← Home
Nestlé 
Food & nutrition / Food and beverage
📢 Press Releases
| Date | Press release |
|---|---|
| 2025-05-20 06:00:00 | Moloco, NestlÉ-purina, Snapchat, And Mistplay Discuss The Rise Of The Independent App Ecosystem At Mau Vegas 2025 Las vegas--(business wire)--moloco, a leader in operational machine learning (ml) and performance advertising, today announced it will be participating in the event mobile apps unlocked (mau) vegas 2025. as a title sponsor of this event, moloco will lead a customer panel session featuring nestlÉ-purina, snapchat, and mistplay; present a keynote session; and offer an interactive booth experience with an informative quiz that tests how well marketers know their target audiences. beth berger, vice. |
| 2024-09-30 17:15:00 | Seres Therapeutics Announces Completion Of Vowst™ Asset Sale To SociÉtÉ Des Produits NestlÉ S.a Transaction supports further development of ser-155, following recent promising clinical data, and other cultivated live biotherapeutics, for multiple medically vulnerable patient populations at high risk of life-threatening bacterial infections |
| 2024-09-27 15:26:00 | Seres Therapeutics Stockholders Issue Open Letter To Board Of Directors Regarding Reported Engagement With NestlÉ Geneva--(business wire)--lucien selce and mkt capital ltd. (together, “we”), who collectively own 1.4 million shares of seres therapeutics inc. (nasdaq: mcrb) (“seres” or the “company”), today published the following open letter to the company’s board of directors (the “board”). *** september 27, 2024 members of the board, we are writing to you today as a stockholder of seres who is seeking additional information regarding the company’s planned sale of its vowst business to nestlÉ health scienc. |
| 2024-08-06 07:00:00 | Seres Therapeutics Announces Signing Of Vowst™ Asset Purchase Agreement With NestlÉ Health Science Upon closing, seres to receive $175m cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in seres common stock, less approximately $20m in settlement of net obligations between the parties; anticipated deal closing in the next 90 days |
| 2024-06-06 07:00:00 | NestlÉ Health Science Agrees To Acquire Global Rights To Vowst®, Product It Launched In June 2023 Transaction ensures nestlÉ health science will continue to commercialize the product bridgewater, n.j. , june 6, 2024 /prnewswire/ -- seres therapeutics, inc. (nasdaq: mcrb), announced today that it has agreed to a non-binding memorandum of understanding with nestlÉ health science in which nestlÉ health science will acquire certain tangible and intangible assets associated with vowst (fecal microbiota spores, live-brpk) capsules. |
📰 Browse additional press releases for Nestlé!
Sign up for free or log in📝 Join us and grab your copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks"